Cross Country Healthcare (CCRN) Tops Q1 EPS by 2c ; Offers Guidance

Cross Country Healthcare (NASDAQ: CCRN) reported Q1 EPS of $0.19, $0.02 better than the analyst estimate of $0.17. Revenue for the quarter came in at $379.17 million versus the consensus estimate of $374.37 million.

GUIDANCE:

Cross Country Healthcare sees Q2 2024 EPS of $0.10-$0.20, versus the consensus of $0.18. Cross Country Healthcare sees Q2 2024 revenue of $330-340 million, versus the consensus of $362.7 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• SanDisk upgraded at JPMorgan after investor day; shares climb